- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Advances in Virology
Volume 2011 (2011), Article ID 940210, 10 pages
Endogenous Murine Leukemia Viruses: Relationship to XMRV and Related Sequences Detected in Human DNA Samples
Department of Molecular Biology and Microbiology and Genetics Program, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA 02111, USA
Received 15 June 2011; Accepted 7 July 2011
Academic Editor: Arifa S. Khan
Copyright © 2011 Oya Cingöz and John M. Coffin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. M. Coffin, S. H. Hughes, and H. Varmus, Retroviruses, Cold Spring Harbor Laboratory Press, Plainview, NY, USA, 1997.
- E. Herniou, J. Martin, K. Miller, J. Cook, M. Wilkinson, and M. Tristem, “Retroviral diversity and distribution in vertebrates,” Journal of Virology, vol. 72, no. 7, pp. 5955–5966, 1998.
- K. Tomonaga and J. M. Coffin, “Structures of endogenous nonecotropic murine leukemia virus (MLV) long terminal repeats in wild mice: implication for evolution of MLVs,” Journal of Virology, vol. 73, no. 5, pp. 4327–4340, 1999.
- C. Stocking and C. A. Kozak, “Endogenous retroviruses: murine endogenous retroviruses,” Cellular and Molecular Life Sciences, vol. 65, no. 21, pp. 3383–3398, 2008.
- J. P. Stoye and J. M. Coffin, “The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination,” Journal of Virology, vol. 61, no. 9, pp. 2659–2669, 1987.
- L. M. Albritton, L. Tseng, D. Scadden, and J. M. Cunningham, “A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection,” Cell, vol. 57, no. 4, pp. 659–666, 1989.
- C. A. Kozak, “The mouse “xenotropic” gammaretroviruses and their XPR1 receptor,” Retrovirology, vol. 7, no. 1, article 101, 2010.
- K. S. Sfanos, A. L. Aloia, J. L. Hicks, et al., “Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines,” PLoS ONE, vol. 6, no. 6, article e20874, 2011.
- J. W. Hartley, N. K. Wolford, L. J. Old, and W. P. Rowe, “A new class of murine leukemia virus associated with development of spontaneous lymphomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 2, pp. 789–792, 1977.
- P. Jern, J. P. Stoye, and J. M. Coffin, “Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses,” PLoS Genetics, vol. 3, no. 10, article e183, pp. 2014–2022, 2007.
- S. Neil and P. Bieniasz, “Human immunodeficiency virus, restriction factors, and interferon,” Journal of Interferon and Cytokine Research, vol. 29, no. 9, pp. 569–580, 2009.
- A. Urisman, R. J. Molinaro, N. Fischer et al., “Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant,” PLoS Pathogens, vol. 2, no. 3, article e25, 2006.
- V. C. Lombardi, F. W. Ruscetti, J. D. Gupta et al., “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome,” Science, vol. 326, no. 5952, pp. 585–589, 2009.
- S. C. Lo, N. Pripuzova, B. Li et al., “Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 36, pp. 15874–15879, 2010.
- E. C. Knouf, M. J. Metzger, P. S. Mitchell et al., “Multiple integrated copies and high-level production of the human retrovirus XMRV (Xenotropic Murine leukemia virus-Related Virus) from 22Rv1 prostate carcinoma cells,” Journal of Virology, vol. 83, no. 14, pp. 7353–7356, 2009.
- M. Cornelissen, F. Zorgdrager, P. Blom et al., “Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands,” PLoS ONE, vol. 5, no. 8, article e12040, 2010.
- J. J. Rodriguez and S. P. Goff, “Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells,” Journal of Virology, vol. 84, no. 5, pp. 2556–2562, 2010.
- R. M. Sramkoski, T. G. Pretlow, J. M. Giaconia et al., “A new human prostate carcinoma cell line, 22Rv1,” In Vitro Cellular and Developmental Biology—Animal, vol. 35, no. 7, pp. 403–409, 1999.
- T. Paprotka, K. A. Delviks-Frankenberry, O. Cingöz, et al., “Recombinant origin of the retrovirus XMRV,” Science, vol. 333, no. 6038, pp. 97–101, 2011.
- J. Zhuang, S. Mukherjee, Y. Ron, and J. P. Dougherty, “High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy,” Journal of Virology, vol. 80, no. 13, pp. 6706–6711, 2006.
- T. S. Tralka, C. L. Yee, A. B. Rabson, et al., “Murine type C retroviruses and intracisternal A-particles in human tumors serially passaged in nude mice,” Journal of the National Cancer Institute, vol. 71, no. 3, pp. 591–599, 1983.
- J. A. Levy and T. Pincus, “Demonstration of biological activity of a murine leukemia virus of New Zealand black mice,” Science, vol. 170, no. 3955, pp. 326–327, 1970.
- B. G. Achong, P. A. Trumper, and B. C. Giovanella, “C type virus particles in human tumours transplanted into nude mice,” British Journal of Cancer, vol. 34, no. 2, pp. 203–206, 1976.
- H. Wunderli, D. D. Mickey, and D. F. Paulson, “C-type virus particles in human urogenital tumours after heterotransplantation into nude mice,” British Journal of Cancer, vol. 39, no. 1, pp. 35–42, 1979.
- R. Mendoza, A. E. Vaughan, and A. D. Miller, “The left half of the XMRV retrovirus is present in an endogenous retrovirus of NIH/3T3 swiss mouse cells,” Journal of Virology, vol. 85, no. 17, pp. 9247–9248, 2011.
- T. Paprotka, N. J. Venkatachari, C. Chaipan et al., “Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs,” Journal of Virology, vol. 84, no. 11, pp. 5719–5729, 2010.
- B. Oakes, A. K. Tai, O. Cingöz et al., “Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences,” Retrovirology, vol. 7, no. 1, p. 109, 2010.
- M. J. Robinson, O. W. Erlwein, S. Kaye et al., “Mouse DNA contamination in human tissue tested for XMRV,” Retrovirology, vol. 7, no. 1, p. 108, 2010.
- C. Qin, Z. Wang, J. Shang et al., “Intracisternal a particle genes: distribution in the mouse genome, active subtypes, and potential roles as species-specific mediators of susceptibility to cancer,” Molecular Carcinogenesis, vol. 49, no. 1, pp. 54–67, 2010.
- K. Knox, D. Carrigan, G. Simmons, et al., “No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected,” Science, vol. 333, no. 6038, pp. 94–97, 2011.
- E. Sato, R. A. Furuta, and T. Miyazawa, “An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR Kit is amplified using standard primers for XMRV,” Retrovirology, vol. 7, no. 1, p. 110, 2010.
- P. W. Tuke, K. I. Tettmar, A. Tamuri, J. P. Stoye, and R. S. Tedder, “PCR master mixes harbour murine DNA sequences. Caveat emptor!,” PLoS ONE, vol. 6, no. 5, article e19953, 2011.
- C. H. Shin, L. Bateman, R. Schlaberg, et al., “Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome,” The Journal of Virology, vol. 85, no. 14, pp. 7195–7202, 2011.
- J. P. Stoye, R. H. Silverman, C. A. Boucher, and S. F. J. Le Grice, “The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop,” Retrovirology, vol. 7, no. 1, p. 113, 2010.
- C. Y. Thomas, R. Khiroya, R. S. Schwartz, and J. M. Coffin, “Role of recombinant ecotropic and polytropic viruses in the development of spontaneous thymic lymphomas in HRS/J mice,” Journal of Virology, vol. 50, no. 2, pp. 397–407, 1984.
- J. P. Stoye, C. Moroni, and J. M. Coffin, “Virological events leading to spontaneous AKR thymomas,” Journal of Virology, vol. 65, no. 3, pp. 1273–1285, 1991.
- A. S. Khan, “Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus-forming murine leukemia viruses,” Journal of Virology, vol. 50, no. 3, pp. 864–871, 1984.
- S. Bhosle, S. Suppiah, R. Molinaro et al., “Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells,” Journal of Virology, vol. 84, no. 13, pp. 6288–6296, 2010.
- R. A. Weiss, “A cautionary tale of virus and disease,” BMC Biology, vol. 8, no. 1, p. 124, 2010.
- S. Hue, E. R. Gray, A. Gall et al., “Disease-associated XMRV sequences are consistent with laboratory contamination,” Retrovirology, vol. 7, no. 1, p. 111, 2010.
- Y. Takeuchi, M. O. McClure, and M. Pizzato, “Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research,” Journal of Virology, vol. 82, no. 24, pp. 12585–12588, 2008.
- K. P. Raisch, M. Pizzato, H. Y. Sun, Y. Takeuchi, L. W. Cashdollar, and S. E. Grossberg, “Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75,” Virology, vol. 308, no. 1, pp. 83–91, 2003.
- M. Pizzato, “MLV glycosylated-gag is an infectivity factor that rescues Nef-deficient HIV-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 20, pp. 9364–9369, 2010.